New drug aims to help patients shed pounds after failed weight-loss surgery
NCT ID NCT07163650
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called efsubaglutide alfa to help people who are still obese six months after weight-loss surgery lose more weight. About 60 adults aged 18 to 55 with a BMI of 28 or higher will take the drug or a placebo. The main goal is to see how much weight they lose and if the drug is safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLP-1 RECEPTOR AGONIST are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanjing Drum Tower Hospital
RECRUITINGNanjing, Jiangsu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?